Gingyo-san is composed of 10 crude drugs and used as a traditional
antipyretic medicine for the treatment of the
common cold and influenza virus
infection. In a murine intranasal
influenza infection model,
fever produced by the
infection has been demonstrated to be reduced by suppressing
interferon-induced
interleukin (IL)-1 alpha production. Thus, we focused on the serum level of
IL-1 alpha which produces such novel
antipyretic activity, and evaluated the relationship between defervescence and the suppression of
IL-1 alpha production by
Gingyo-san in influenza virus-infected mice.
Fever was produced in the infected mice 33-44 h after
infection.
Oral administration of a hot water-extract of
Gingyo-san (8.9-12.5 mg/0.25 ml/mouse x 3 per day) significantly reduced
fever production and suppressed the rise in
IL-1 alpha production to the level in uninfected mice. No apparent toxicity by
Gingyo-san was observed in infected mice. When the hot water-extract of each 10 of the crude components of
Gingyo-san (an unknown amount extracted from 6.25 mg/0.25 ml/mouse x 3 per day for Saigae Tataricae Cornu and 3.5 mg/0.25 ml/mouse x 3 per day for the other 9) was orally administered to infected mice, 6 showed significant
antipyretic activity. Of these 6, Saigae Tatricae Cornu significantly suppressed the rise in
IL-1 alpha production to the basal level while the other 5 did not affect serum
IL-1 alpha. Thus, of the 10 crude components of
Gingyo-san, Saigae Tataricae Cornu simultaneously exhibited
antipyretic and
IL-1 alpha-regulatory activities. The novel
antipyretic action of
Gingyo-san may be mainly mediated by Saigae Tataricae Cornu which regulates the elevated serum
IL-1 alpha level produced by
influenza infection.